The Antimicrobial Resistance (AMR) contributes to more than 700,000 deaths annually and considered a major global health catastrophe. Due to the ineffectiveness of the majority of the existing drugs against multidrug-resistant (MDR)strains of bacteria and fungi, there is an unmet need for newer potent antimicrobials. The PeptomerTherapeutics has invented novel platforms that help to develop a range of antimicrobial peptides and oligomers. We are based at the BSC BioNEST Bio-Incubator, Regional Centre for Biotechnology (RCB), Faridabad.

Dr Kantaraja ChinderaDr Ravindra P VeerannaPrincyYash Ranga
Director and Co-founderCo-founderSenior ScientistFormulation Chemist Scientist
Vanshika-RahejaSimran VashishthSanoj
Research ScientistResearch ScientistLab Technician
Deepika ChaudharyAnshulAnjali Pandey
Research ScientistResearch ScientistResearch Scientist